EUVIMED · CrossrefZeitschrift
ALTEX - Alternatives to Animal Experimentation
ISSN 1868-8551 · ALTEX Edition
Neueste Artikel
Linking nuclear receptor antagonism with neuronal morphology improves detection of developmental neurotoxicants
Linking nuclear receptor antagonism with neuronal morphology improves detection of developmental neurotoxicants_suppl
Beyond the drug-centric view: Advancing AI virtual cell platforms for environmental perturbation modelling
Borrow, don't breed: How historical controls can cut concurrent animal numbers
Borrow, don't breed: How historical controls can cut concurrent animal numbers_suppl
HepaRGTM CYP induction test method augmentation part 1: The GOLIATH Study
HepaRGTM CYP induction test method augmentation part 1: The GOLIATH Study_suppl
HepaRGTM CYP induction test method augmentation part 2: Study supported by mRNA analysis
HepaRGTM CYP induction test method augmentation part 2: Study supported by mRNA analysis_suppl
Educational and training needs of regulatory professionals for non-animal methodologies: Insights from a survey
Educational and training needs of regulatory professionals for non-animal methodologies: Insights from a survey_suppl1
Educational and training needs of regulatory professionals for non-animal methodologies: Insights from a survey_suppl2
Educational and training needs of regulatory professionals for non-animal methodologies: Insights from a survey_suppl3
R3FINE 2026: Bridging disciplinary gaps in translational animal-free research
Validation by design: Model-informed validation design (MIVD) as a quantitative design science
Validation by design: Model-informed validation design (MIVD) as a quantitative design science_suppl
ECHA writes back: The reasons for rejection of read-across in compliance check decisions by the European Chemicals Agency
ECHA writes back: The reasons for rejection of read-across in compliance check decisions by the European Chemicals Agency_suppl1
ECHA writes back: The reasons for rejection of read-across in compliance check decisions by the European Chemicals Agency_suppl2
ECHA writes back: The reasons for rejection of read-across in compliance check decisions by the European Chemicals Agency_suppl3
ECHA writes back: The reasons for rejection of read-across in compliance check decisions by the European Chemicals Agency_suppl4
ECHA writes back: The reasons for rejection of read-across in compliance check decisions by the European Chemicals Agency_suppl5
A roadmap for modernizing vaccine safety assessment: Challenges and opportunities for new approach methodologies
EUVIMED